Literature DB >> 26440755

Epidemiology of tinea capitis in northeast Iran: a retrospective analysis from 1998 to 2012.

Parvaneh Afshar1, Lale Vahedi2, Maryam Ghasemi2, Alireza Mardanshahi3.   

Abstract

BACKGROUND: Tinea capitis is a common disease of the pediatric population. This disease typically follows one of several clinical patterns, i.e., scaling, hair loss, and/or inflammatory lesions, which are usually caused predominantly by two dermatophytic genera: Microsporum and Trichophyton. The aim of this study was to investigate tinea capitis and its etiological agents in Sari city of Mazandaran province, Iran.
METHODS: We studied the spectrum of tinea capitis by means of a retrospective analysis involving 1745 patients referred to both the Reference Laboratory of Medical Mycology (RLMM) and Bo Ali Sina Hospital at Sari, Iran (1998-2012). Specimens were assessed by standard mycological techniques based on macroscopic and microscopic morphology.
RESULTS: Among the patients, 480 (27.5%; 61 males and 39% females) were confirmed through a mycological examination. The peak incidence was in the 5-14 years age group. Endothrix (263 cases; 54.8%) was the most frequent clinical feature by direct exam. The predominant causative agents of tinea capitis were T. tonsurans (186 cases; 38.8%) and T. violaceum (119 cases; 24.8%), followed by T. mentagrophytes (46 cases; 9.6%), T. schoenleinii (28; 5.8%), T. rubrum (20 cases; 4.2%), M. gypseum (15 cases; 3.1%), T. verrucosum (14 cases; 2.9%), and Epidermophyton floccosum (1 cases; 0.2%).
CONCLUSION: The present study showed that tinea capitis is mainly due to the anthropophilic species, and the most common species were T. tonsurans and T. violaceum. Owing to the high frequency of anthropophilic species, future studies may be useful in the development of preventive and educational strategies to reduce healthcare expenditure.
© 2015 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2015        PMID: 26440755     DOI: 10.1111/ijd.12888

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.

Authors:  Mahdi Abastabar; Maryam Babaei; Rasoul Mohammadi; Reza Valadan; Javad Javidnia; Arezoo Zaedi; Seyed Reza Aghili; Iman Haghani; Shaghayegh Khojasteh; Ali Reazaei-Matehkolaei; Neda Kiasat; Kambiz Kamyab Hesari; Zeinab Ghasemi; Maryam Azish; Hossein Zarrinfar; Mojtaba Taghizadeh-Armaki; Naser Keikha; Mahboobeh Kharazi; Hossein Khodadadi; Mohammad Taghi Hedayati; Tahereh Shokohi
Journal:  Mycopathologia       Date:  2022-08-18       Impact factor: 3.785

2.  Clinico-mycological profile of tinea capitis and its comparative response to griseofulvin versus terbinafine.

Authors:  Ali Mikaeili; Hossein Kavoussi; Amir Hosein Hashemian; Mahdokht Shabandoost Gheshtemi; Reza Kavoussi
Journal:  Curr Med Mycol       Date:  2019-03

3.  Tinea capitis: a retrospective epidemiological comparative study.

Authors:  A A Chokoeva; L Zisova; E Sotiriou; T Miteva-Katrandzhieva
Journal:  Wien Med Wochenschr       Date:  2016-08-10

4.  A comparison of conventional rapid methods in diagnosis of superficial and cutaneous mycoses based on KOH, Chicago sky blue 6B and calcofluor white stains.

Authors:  Parvaneh Afshar; Laleh Vahedi Larijani; Hamed Rouhanizadeh
Journal:  Iran J Microbiol       Date:  2018-12

5.  Presence of Malassezia Hyphae Is Correlated with Pathogenesis of Seborrheic Dermatitis.

Authors:  Juanjuan Li; Yahui Feng; Chen Liu; Zhiya Yang; Sybren de Hoog; Yuying Qu; Biao Chen; Dongmei Li; Huabao Xiong; Dongmei Shi
Journal:  Microbiol Spectr       Date:  2022-01-12

6.  Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.

Authors:  James Powell; Emma Porter; Sinead Field; Nuala H O'Connell; Kieran Carty; Colum P Dunne
Journal:  Mycoses       Date:  2022-07       Impact factor: 4.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.